2 results
Approved WMOCompleted
To study the potential of baclofen as an anti-craving/relapse agent in GHB dependent patients.
Approved WMOCompleted
*To demonstrate comparability of the ORR in patients with previously untreated, advanced stage FL who receive GP2013-CVP combination treatment to patients who receive MabThera®-CVP treatment. ORR will be determined during the combination treatment…